SCHEMBL29409302

SCHEMBL29409302

CCOC(=O)C1Cc2ccccc2CN1C(=O)c1ccc(F)cc1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NR1D1 P20393 4/20 0.64
BCL2 P10415 1/20 0.50
BAD Q92934 1/20 0.50
PDE4B Q07343 1/20 0.49
PDE4D Q08499 1/20 0.49
LMNA P02545 1/20 0.48
PKM P14618 1/20 0.48
HTR1A P08908 2/20 0.46
HTR7 P34969 2/20 0.46
MMP9 P14780 2/20 0.46
MMP1 P03956 1/20 0.46
MMP3 P08254 1/20 0.46
ADAM9 Q13443 1/20 0.46
MEN1 O00255 2/20 0.45
MAPT P10636 2/20 0.45
KMT2A Q03164 2/20 0.45
PABPC1 P11940 1/20 0.45
CFTR P13569 2/20 0.45
GAA P10253 1/20 0.44
L3MBTL1 Q9Y468 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28555813 1.00 NR1D1 (0.64) NR1D1BCL2BADPDE4BPDE4D
SCHEMBL29409298 0.89 NR1D1 (0.62) NR1D1BCL2BADPDE4BPDE4D
SCHEMBL28550513 0.89 NR1D1 (0.62) NR1D1BCL2BADPDE4BPDE4D
SCHEMBL19931770 0.86 NR1D1 (0.53) NR1D1BCL2BADHTR1AHTR7
SCHEMBL29409308 0.83 NR1D1 (0.61) NR1D1BCL2BADPDE4BPDE4D
SCHEMBL28912058 0.83 NR1D1 (0.61) NR1D1BCL2BADPDE4BPDE4D
SCHEMBL29409301 0.82 NR1D1 (0.68) NR1D1BCL2BADGAA
SCHEMBL28556786 0.82 NR1D1 (0.68) NR1D1BCL2BADGAA
SCHEMBL23093165 0.81 LMNA (0.55) LMNAPKMHTR1AHTR7MMP3
SCHEMBL29715382 0.81 LMNA (0.55) LMNAPKMHTR1AHTR7MMP3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112752837-B Natural killer cells 帝国理工学院创新有限公司 2026-05-15 CN disclosed
US-12377119-B2 Natural killer cells IMPERIAL COLLEGE INNOVATIONS LIMITED (GB) 2025-08-05 US disclosed
US-20220073880-A1 NATURAL KILLER CELLS IMPERIAL COLLEGE INNOVATIONS LIMITED (GB) 2022-03-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220073880-A1 NATURAL KILLER CELLS PBK, IKZF3, IKZF1 NR1D1 2299/4885BCL2 1261/4885BAD 1434/4885
US-12377119-B2 Natural killer cells PBK, IKZF3, IKZF1 NR1D1 2299/4885BCL2 1261/4885BAD 1434/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.